Archive for ‘Pulmonary Monitor’

ExSpiron Pulmonary Monitor Continuously Tracks Lung Performance

ExSpiron Pulmonary Monitor Continuously Tracks Lung Performance

ExSpiron Pulmonary Monitor Continuously Tracks Lung Performance

Lacking an easy to use monitoring device that provides a quantitative metric, decisions regarding respiratory adequacy have been surprisingly haphazard. This results in unnecessary respiratory arrests which are dangerous to patients and expensive for the provider. There is an unmet medical need for a monitor that can reliably provide a quantitative measure of ventilation and can serve as a leading indicator of respiratory failure.

Mass. ¨C October 10, 2012 ¨C Respiratory Motion, Inc. today announced 510(k)

clearance from the US Food and Drug Administration (FDA) for its ExSpiron respiratory

monitoring system, the first to provide continuous, noninvasive Minute Ventilation data in nonventilated

patients. A presentation on the technology will be given at the American Society of

Anesthesiologists (ASA) annual conference on October 16. .

Minute Ventilation data (the amount of air that enters/leaves the lungs every minute) ¨C along

with ExSpiron¡¯s other respiratory data ¨C are vital, quantitative measures of breathing that have

not been previously available to physicians across the continuum of care.

In the hospital, changes in breathing status often precede deterioration towards respiratory

depression and arrest. In-hospital cardiopulmonary arrests are estimated to be as high as

750,000 annually, leading to 50,000 deaths. Respiratory depression can occur partly in

response to medications, such as narcotic painkillers and sedatives commonly administered

after surgery. Given the strength of these medications and the fact that each patient¡¯s response

is unique ¨C respiratory depression can strike even when least expected. Averting respiratory

failure via early detection can reduce catastrophic events, improve patient care and outcomes,

decrease healthcare costs, and save lives. .

¡°As a cardiothoracic surgeon, I am all too aware of the grave threat that respiratory depression

presents post-operatively or in other scenarios where respiration is compromised such as with

opioid therapy or in certain disease states,¡± . states Jenny E. Freeman, MD and CEO of

Respiratory Motion, Inc. ¡°Respiratory Motion¡¯s ExSpiron provides the same volume metrics that

physicians have come to rely on to manage patients on mechanical ventilators. We are now

making these measurements continuously available for non-ventilated patients via a small,

noninvasive bedside monitor. Respiratory Motion, Inc. has been created to develop

technologies to assist clinicians in their fight against respiratory depression and help improve

patient safety. We have seen significant physician interest in our technology and are pleased to

be providing a new, quantitative tool to help address this critically important challenge that is

faced every day in caring for patients following surgery.¡± .

Both the Anesthesia Patient Safety Foundation (apsf) and the American Society of

Anesthesiologists (ASA) encourage improved ventilation assessment to help combat adverse

respiratory events; with the ASA officially adding to its practice standards the continual

observation of ventilation in any patient following anesthesia. .

Traditional clinical observations and bedside monitoring of respiratory status can be late

indicators of decompensation in non-ventilated patients, such as those in the post-op recovery

room. Underlying physiology, published studies and tragic case reports support the need for

better monitoring. .

ExSpiron¡¯s industry-unique combination of respiratory metrics was designed to provide

continuous, accurate quantitative readings of Minute Ventilation (the amount of air that

enters/leaves the lungs every minute) never before continuously captured in non-ventilated

patients; respiration rate (breaths per minute); and tidal volume (the volume of air in a single

breath). The system is also clinically practical and patient-friendly. Monitoring can be performed

by nurses, physicians or other healthcare clinicians by simply applying a chest sensor to the

patient, after which data is generated continuously and automatically. .

The addition of Minute Ventilation data and its trending over time provides new objective metrics

to assist clinicians in the immediate evaluation of the pulmonary system and demonstrates

changes in respiratory status. .

.

¡°This device stands to provide a quantitative metric of respiratory function much in the same

manner that cardiac monitoring did for cardiac and intensive care patients,¡± explains Gary John

Mullen, MD, an anesthesiologist at Vidant Healthcare in North Carolina and a clinical advisor to

the company. ¡°The ExSpiron will help nurses and care teams keep a constant watch on the high

volume of patients under their care and feed them real-time, quantitative data as an important

adjunct to patient assessment and decision making.¡±

Given the known challenge in the medical community for improved respiratory monitoring and

the new quantitative solution that ExSpiron is delivering, Respiratory Motion has an increasing

presence at clinical conferences. Upcoming clinical presentations of the ExSpiron technology

will take place at the annual conferences of the American Society of Anesthesiologists,

American College of Chest Physicians, American Heart Association and Society of Critical Care

Medicine, all within the next three months, with additional presentations later in 2013. These

follow a series of other notable presentations in the past year at conferences of the American

Thoracic Society, Society of Critical Care Medicine, American Heart Association, American Pain

Society, American Academy of Pain Medicine and Smart Monitoring. .

The ExSpiron will be available for clinicians beginning in January 2013 in the initial hospital

settings of anesthesia/OR, post-op recovery and intensive care units. .

About the ExSpiron Respiratory Volume Monitor .

ExSpiron continuously and noninvasively measures and displays lung volume against time,

generating quantitative metrics for minute ventilation (the amount of air that enters/leaves the

lungs every minute), respiratory rate (breaths per minute), and tidal volume (the volume of air in

a single breath). Minute ventilation was previously only captured continuously via mechanical

ventilators, or gauged intermittently via a spirometer in patients mentally and physically able to

perform the test. The ExSpiron monitor now brings this capability to assess patients¡¯ respiratory

status continuously to the point of care. ExSpiron is for use on adult patients as an adjunct to

other clinical data. .

About Respiratory Motion, Inc. . .

Respiratory Motion, Inc. is a private medical device company based in Waltham, Massachusetts

focused on the development and commercialization of innovative devices to monitor respiration.

RESPIRATORY MOTION RECEIVES 510(k) CLEARANCE FOR EXSPIRON MONITOR, THE FIRST

MONITOR TO PROVIDE CONTINUOUS MINUTE VENTILATION DATA IN NON-VENTILATED

PATIENTS ¨C Page 3 of 3 .

.

.

Its mission is to create respiratory technologies and products that help clinicians and hospitals

improve patient safety and outcomes. www.respiratorymotion.

Monitoring patient ventilation is important for those on a mechanical ventilator, but once natural breathing is restored clinicians typically lose their ability to watch for changes in the volume of air the patient is moving per minute. Respiratory Motion Inc., a company out of Waltham, MA, just received FDA 510(k) clearance to introduce its ExSpiron non-invasive ventilation monitor to U.S. hospitals.

The system can be used after little training by any clinician by simply applying the monitoring patch to the chest and connecting it to the electronic monitor. The device automatically begins watching the lungs and displays continuous readings on its color monitor. The company will be presenting the device next week at the American Society of Anesthesiologists (ASA) annual conference in Washington, D.C.

From the announcement:

Respiratory depression can occur partly in response to medications, such as narcotic painkillers and sedatives commonly administered after surgery. Given the strength of these medications and the fact that each patient’s response is unique –respiratory depression can strike even when least expected. Averting respiratory failure via early detection canreduce catastrophic events, improve patient care and outcomes, decrease healthcare costs, and save lives.

ExSpiron’s industry-unique combination of respiratory metrics was designed to provide continuous, accurate quantitative readings of Minute Ventilation (the amount of air that enters/leaves the lungs every minute) never before continuously captured in non-ventilated patients; respiration rate (breaths per minute); and tidal volume (the volume of airin a single breath). The system is also clinically practical and patient-friendly. Monitoring can be performed by nurses, physicians or other healthcare clinicians by simply applying a chest sensor to the patient, after which data is generated continuously and automatically.”

The addition of Minute Ventilation data and its trending over time provides new objective metrics to assist clinicians in the immediate evaluation of the pulmonary system and demonstrates changes in respiratory status.

Source : http://www.respiratorymotion.com/exspiron/

Related Posts Plugin for WordPress, Blogger...

Full story

Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes